analysis suite software Search Results


cbis data analysis suite  (ChemInnovation Software Inc)
90
ChemInnovation Software Inc cbis data analysis suite
Cbis Data Analysis Suite, supplied by ChemInnovation Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/analysis+suite+software/cbis+data+analysis+suite/pmc06863850-300-5-9
Average 90 stars, based on 1 article reviews
cbis data analysis suite - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
software-based image analyzing system vis software suite  (Visiopharm AS)
90
Visiopharm AS software-based image analyzing system vis software suite
Software Based Image Analyzing System Vis Software Suite, supplied by Visiopharm AS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/analysis+suite+software/image+analysis+software+vis+software+suite/pm36131941-101-7-13
Average 90 stars, based on 1 article reviews
software-based image analyzing system vis software suite - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
chemical and biological information systems data analysis suite cbis  (ChemInnovation Software Inc)
90
ChemInnovation Software Inc chemical and biological information systems data analysis suite cbis
Chemical And Biological Information Systems Data Analysis Suite Cbis, supplied by ChemInnovation Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/analysis+suite+software/chemical+and+biological+information+systems+data+analysis+suite+cbis/pmc06606843-74-7-14
Average 90 stars, based on 1 article reviews
chemical and biological information systems data analysis suite cbis - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
lunaris analysis suite software  (AYOXXA Inc)
90
AYOXXA Inc lunaris analysis suite software
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Lunaris Analysis Suite Software, supplied by AYOXXA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/analysis+suite+software/lunaristm+analysis+suite+software/pmc08962359-62-6-12
Average 90 stars, based on 1 article reviews
lunaris analysis suite software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
vida pulmonary workstation software  (VIDA Diagnostics)
90
VIDA Diagnostics vida pulmonary workstation software
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Vida Pulmonary Workstation Software, supplied by VIDA Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/analysis+suite+software/pulmonary+analysis+software+suite/pmc04216374-116-12-16
Average 90 stars, based on 1 article reviews
vida pulmonary workstation software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
earray expression analysis suite 2.0 software  (SuperArray Bioscience Corporation)
90
SuperArray Bioscience Corporation earray expression analysis suite 2.0 software
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Earray Expression Analysis Suite 2.0 Software, supplied by SuperArray Bioscience Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/analysis+suite+software/earray+expression+analysis+suite+2+0+software/pm19185596-108-13-19
Average 90 stars, based on 1 article reviews
earray expression analysis suite 2.0 software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
analysis software tivita ® suite tissue  (Diaspective Vision GmbH)
90
Diaspective Vision GmbH analysis software tivita ® suite tissue
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Analysis Software Tivita ® Suite Tissue, supplied by Diaspective Vision GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/analysis+suite+software/analysis+software+tivita+++suite+tissue/pmc11473603-48-12-18
Average 90 stars, based on 1 article reviews
analysis software tivita ® suite tissue - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
visualization and analysis software ap suite 6.3.0.90  (CAMECA Inc)
90
CAMECA Inc visualization and analysis software ap suite 6.3.0.90
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Visualization And Analysis Software Ap Suite 6.3.0.90, supplied by CAMECA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/analysis+suite+software/integrated+visualization+and+analysis+software+ap+suite+version+6+1+0+29/pm38708934__nl4c01484_si_001-64-58-55
Average 90 stars, based on 1 article reviews
visualization and analysis software ap suite 6.3.0.90 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
custom software suite  (Trium Analysis Online GmbH)
90
Trium Analysis Online GmbH custom software suite
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Custom Software Suite, supplied by Trium Analysis Online GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/analysis+suite+software/custom+software+suite/pmc08203655-96-15-23
Average 90 stars, based on 1 article reviews
custom software suite - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
chromosome analysis suite software  (BioDiscovery Inc)
90
BioDiscovery Inc chromosome analysis suite software
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Chromosome Analysis Suite Software, supplied by BioDiscovery Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/analysis+suite+software/chromosome+analysis+suite+software/pmc09550834-163-5-17
Average 90 stars, based on 1 article reviews
chromosome analysis suite software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
archer suite analysis v7.1 software  (Danaher)
90
Danaher archer suite analysis v7.1 software
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Archer Suite Analysis V7.1 Software, supplied by Danaher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/analysis+suite+software/archer+suite+analysis+v7+1+software/10__1016_slash_j__hpr__2024__300761-54-17-22
Average 90 stars, based on 1 article reviews
archer suite analysis v7.1 software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
data analysis facility suite software  (Voronoi Health Analytics)
90
Voronoi Health Analytics data analysis facility suite software
Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a <t>LUNARIS</t> assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
Data Analysis Facility Suite Software, supplied by Voronoi Health Analytics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/analysis+suite+software/data+analysis+facility+suite+software/pm37562946-244-24-12
Average 90 stars, based on 1 article reviews
data analysis facility suite software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a LUNARIS assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.

Journal: Biomedicines

Article Title: Chemokine CCL9 Is Upregulated Early in Chronic Kidney Disease and Counteracts Kidney Inflammation and Fibrosis

doi: 10.3390/biomedicines10020420

Figure Lengend Snippet: Systemic antibody-mediated blocking of CCL9 increases kidney inflammation. As in a, hyperlipidemic ApoE −/− mice with adenine-induced CKD were treated with blocking antibodies against CCL6 (αCCL6 CKD) or CCL9 (αCCL9 CKD), or with isotype-matched antibody controls (Isotype CKD) (n = 3–4). Hyperlipidemic ApoE −/− mice without adenine but with isotype-matched antibody treatment served as non-CKD controls (Isotype Control). ( a ) Flow cytometric analysis of neutrophils, monocytes and macrophages in kidney. ( b , c ) The ratio of ( b ) M2 vs. M1 macrophages and ( c ) Ly-6G high vs. Ly-6G low monocytes in kidney by flow cytometric analysis. ( d ) Chemokine concentration in kidney analyzed using a LUNARIS assay. ( a – d ) Two-way ANOVA ( a ) or one-way ANOVA ( b – d ) with Dunnett’s post-test for multiple comparisons. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.

Article Snippet: Analysis of data was performed using LUNARIS Analysis Suite Software (Version 1.4, Ayoxxa, Cologne, Germany).

Techniques: Blocking Assay, Control, Concentration Assay